Thromboxane

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

WikiDoc Resources for

Thromboxane

Articles

Most recent articles on Thromboxane

Most cited articles on Thromboxane

Review articles on Thromboxane

Articles on Thromboxane in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Thromboxane

Images of Thromboxane

Photos of Thromboxane

Podcasts & MP3s on Thromboxane

Videos on Thromboxane

Evidence Based Medicine

Cochrane Collaboration on Thromboxane

Bandolier on Thromboxane

TRIP on Thromboxane

Clinical Trials

Ongoing Trials on Thromboxane at Clinical Trials.gov

Trial results on Thromboxane

Clinical Trials on Thromboxane at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thromboxane

NICE Guidance on Thromboxane

NHS PRODIGY Guidance

FDA on Thromboxane

CDC on Thromboxane

Books

Books on Thromboxane

News

Thromboxane in the news

Be alerted to news on Thromboxane

News trends on Thromboxane

Commentary

Blogs on Thromboxane

Definitions

Definitions of Thromboxane

Patient Resources / Community

Patient resources on Thromboxane

Discussion groups on Thromboxane

Patient Handouts on Thromboxane

Directions to Hospitals Treating Thromboxane

Risk calculators and risk factors for Thromboxane

Healthcare Provider Resources

Symptoms of Thromboxane

Causes & Risk Factors for Thromboxane

Diagnostic studies for Thromboxane

Treatment of Thromboxane

Continuing Medical Education (CME)

CME Programs on Thromboxane

International

Thromboxane en Espanol

Thromboxane en Francais

Businness

Thromboxane in the Marketplace

Patents on Thromboxane

Experimental / Informatics

List of terms related to Thromboxane

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Thromboxane is a member of the family of lipids known as eicosanoids. The two major thromboxanes are thromboxane A2 and thromboxane B2.

Thromboxane is named for its role in clot formation (thrombosis).

Production

Enzymes and substrates associated with thromoboxane and prostacyclin synthesis.
Enzymes and substrates associated with thromoboxane and prostacyclin synthesis.
Eicosanoid synthesis.
Eicosanoid synthesis.

It is produced in platelets by thromboxane-A synthase from the endoperoxides produced by the cyclooxygenase (COX) enzyme from arachidonic acid.

Mechanism

Thromboxane acts by binding to any of the thromboxane receptors, G-protein coupled receptors coupled to the G protein Gq[1].

Functions

Thromboxane is a vasoconstrictor and a potent hypertensive agent, and it facilitates platelet aggregation.

It is in homeostatic balance in the circulatory system with prostacyclin, a related compound. The mechanism of secretion of thromboxanes from platelets is still unclear.

Role of A2 in platelet aggregation

Thromboxane A2 (TXA2), produced by activated platelets, has prothrombotic properties, stimulating activation of new platelets as well as increasing platelet aggregation.

Platelet aggregation is achieved by mediating expression of the glycoprotein complex GP IIb/IIIa in the cell membrane of platelets. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot.

Pathology

It is believed that the vasoconstriction caused by thromboxanes plays a role in Prinzmetal's angina.

Suppression

The widely used drug aspirin acts by inhibiting the ability of the COX enzyme to synthesize the precursors of thromboxane within platelets.

It inhibits the COX enzyme both non-competitively and irreversibly.

The side effect of this is that people who regularly take aspirin will suffer from excessive bleeding whenever the skin is perforated.

External links

de:Thromboxanfr:Thromboxane ja:トロンボキサン

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages